Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	101.44

NSE Code	SUNPHARMA
Dividend Yield %	0.95
Market Cap	4030762.78

P/E	94.12
EPS	17.85
Face Value	1


	BSE		NSE

06-Jun-2025

Last Price	1679.95
Net Change	-3.3
% Change	-0.2%
Prev.Close	1683.25
Open	1689.95
High	1689.95
Low	1669.20
Volume	46947

Last Price	1679.20
Net Change	-3.9
% Change	-0.23%
Prev.Close	1683.10
Open	1685.00
High	1689.00
Low	1669.00
Volume	2500047

Value	78757691
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1689.95
52-Week High	1960.20
52-Week Low	1461.40

Value	4191208633.5
Best Buy	1679.20
Best Sell	0.00
Best Quantity	31
Sell Quantity	0
Today's Range	1689.00
52-Week High	1960.35
52-Week Low	1460.90

Open Price	1688.50
High Price	1697.20
Low Price	1677.90
Last Price	1687.80
Prev Close	1689.70
Change	-1.90
% Change	-0.11 %

Average Price	1685.06
Underlying Value	1679.20
Number of contracts traded	4563
Turnover in Rs. Lakhs	26911
Open Interest	17341450.00
Change in O I	306950.00
% Change in O I	1.80 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	31
Price	1679.20

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	350
Price	1687.7

Quantity	1050
Price	1688.5

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

550 %

07-Jul-25

Company News

26-05-2025

Sun Pharmaceutical Indust...

23-05-2025

Sun Pharmaceutical Indust...

24-04-2025

Sun Pharmaceutical Indust...

14-04-2025

Sun Pharmaceutical Indust...

11-04-2025

US court lifts restrictio...

11-04-2025

Sun Pharma surges after U...

07-04-2025

Sun Pharma launches Fexup...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.